msd Search Results


  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 92
    Novartis msd
    Location of <t>WIPO</t> Re:Search anthelmintic drug development partnerships within the product development pipeline. The majority of partnerships facilitated to date involve the sharing of compounds or compound libraries to be screened against the causative agents of schistosomiasis, soil-transmitted helminthiases, onchocerciasis, lymphatic filariasis, and neurocysticercosis. Partners mentioned in this figure include Aberystwyth University, Alnylam Pharmaceuticals, AstraZeneca (AZ), Drugs for Neglected Diseases initiative (DND i ), Eskitis Institute at Griffith University, GlaxoSmithKline (GSK), Liverpool School of Tropical Medicine (Liverpool STM), McGill University, <t>MSD</t> (known as Merck in the US and Canada), US National Institutes of Health (NIH), Swiss Tropical and Public Health Institute (Swiss TPH), University of British Columbia (UBC), University of California, San Francisco (UCSF), and University of Buea. Capacity-building partnerships are not included in the figure. Asterisks (∗, ∗∗, ∗∗∗) represent partnerships focused on multiple diseases.
    Msd, supplied by Novartis, used in various techniques. Bioz Stars score: 92/100, based on 3762 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/msd/product/Novartis
    Average 92 stars, based on 3762 article reviews
    Price from $9.99 to $1999.99
    msd - by Bioz Stars, 2020-09
    92/100 stars
      Buy from Supplier

    95
    Pfizer Inc msd
    Location of <t>WIPO</t> Re:Search anthelmintic drug development partnerships within the product development pipeline. The majority of partnerships facilitated to date involve the sharing of compounds or compound libraries to be screened against the causative agents of schistosomiasis, soil-transmitted helminthiases, onchocerciasis, lymphatic filariasis, and neurocysticercosis. Partners mentioned in this figure include Aberystwyth University, Alnylam Pharmaceuticals, AstraZeneca (AZ), Drugs for Neglected Diseases initiative (DND i ), Eskitis Institute at Griffith University, GlaxoSmithKline (GSK), Liverpool School of Tropical Medicine (Liverpool STM), McGill University, <t>MSD</t> (known as Merck in the US and Canada), US National Institutes of Health (NIH), Swiss Tropical and Public Health Institute (Swiss TPH), University of British Columbia (UBC), University of California, San Francisco (UCSF), and University of Buea. Capacity-building partnerships are not included in the figure. Asterisks (∗, ∗∗, ∗∗∗) represent partnerships focused on multiple diseases.
    Msd, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 95/100, based on 2809 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/msd/product/Pfizer Inc
    Average 95 stars, based on 2809 article reviews
    Price from $9.99 to $1999.99
    msd - by Bioz Stars, 2020-09
    95/100 stars
      Buy from Supplier

    msd  (AbbVie)
    92
    AbbVie msd
    Location of <t>WIPO</t> Re:Search anthelmintic drug development partnerships within the product development pipeline. The majority of partnerships facilitated to date involve the sharing of compounds or compound libraries to be screened against the causative agents of schistosomiasis, soil-transmitted helminthiases, onchocerciasis, lymphatic filariasis, and neurocysticercosis. Partners mentioned in this figure include Aberystwyth University, Alnylam Pharmaceuticals, AstraZeneca (AZ), Drugs for Neglected Diseases initiative (DND i ), Eskitis Institute at Griffith University, GlaxoSmithKline (GSK), Liverpool School of Tropical Medicine (Liverpool STM), McGill University, <t>MSD</t> (known as Merck in the US and Canada), US National Institutes of Health (NIH), Swiss Tropical and Public Health Institute (Swiss TPH), University of British Columbia (UBC), University of California, San Francisco (UCSF), and University of Buea. Capacity-building partnerships are not included in the figure. Asterisks (∗, ∗∗, ∗∗∗) represent partnerships focused on multiple diseases.
    Msd, supplied by AbbVie, used in various techniques. Bioz Stars score: 92/100, based on 1291 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/msd/product/AbbVie
    Average 92 stars, based on 1291 article reviews
    Price from $9.99 to $1999.99
    msd - by Bioz Stars, 2020-09
    92/100 stars
      Buy from Supplier

    92
    Sanofi sanofi pasteur msd
    Location of <t>WIPO</t> Re:Search anthelmintic drug development partnerships within the product development pipeline. The majority of partnerships facilitated to date involve the sharing of compounds or compound libraries to be screened against the causative agents of schistosomiasis, soil-transmitted helminthiases, onchocerciasis, lymphatic filariasis, and neurocysticercosis. Partners mentioned in this figure include Aberystwyth University, Alnylam Pharmaceuticals, AstraZeneca (AZ), Drugs for Neglected Diseases initiative (DND i ), Eskitis Institute at Griffith University, GlaxoSmithKline (GSK), Liverpool School of Tropical Medicine (Liverpool STM), McGill University, <t>MSD</t> (known as Merck in the US and Canada), US National Institutes of Health (NIH), Swiss Tropical and Public Health Institute (Swiss TPH), University of British Columbia (UBC), University of California, San Francisco (UCSF), and University of Buea. Capacity-building partnerships are not included in the figure. Asterisks (∗, ∗∗, ∗∗∗) represent partnerships focused on multiple diseases.
    Sanofi Pasteur Msd, supplied by Sanofi, used in various techniques. Bioz Stars score: 92/100, based on 1374 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sanofi pasteur msd/product/Sanofi
    Average 92 stars, based on 1374 article reviews
    Price from $9.99 to $1999.99
    sanofi pasteur msd - by Bioz Stars, 2020-09
    92/100 stars
      Buy from Supplier

    msd  (Takeda)
    92
    Takeda msd
    Location of <t>WIPO</t> Re:Search anthelmintic drug development partnerships within the product development pipeline. The majority of partnerships facilitated to date involve the sharing of compounds or compound libraries to be screened against the causative agents of schistosomiasis, soil-transmitted helminthiases, onchocerciasis, lymphatic filariasis, and neurocysticercosis. Partners mentioned in this figure include Aberystwyth University, Alnylam Pharmaceuticals, AstraZeneca (AZ), Drugs for Neglected Diseases initiative (DND i ), Eskitis Institute at Griffith University, GlaxoSmithKline (GSK), Liverpool School of Tropical Medicine (Liverpool STM), McGill University, <t>MSD</t> (known as Merck in the US and Canada), US National Institutes of Health (NIH), Swiss Tropical and Public Health Institute (Swiss TPH), University of British Columbia (UBC), University of California, San Francisco (UCSF), and University of Buea. Capacity-building partnerships are not included in the figure. Asterisks (∗, ∗∗, ∗∗∗) represent partnerships focused on multiple diseases.
    Msd, supplied by Takeda, used in various techniques. Bioz Stars score: 92/100, based on 1007 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/msd/product/Takeda
    Average 92 stars, based on 1007 article reviews
    Price from $9.99 to $1999.99
    msd - by Bioz Stars, 2020-09
    92/100 stars
      Buy from Supplier

    94
    Meso Scale Diagnostics LLC meso scale discovery msd
    Comparison of <t>sAPPα,</t> sAPPβ and t-τ between untreated and treated mild cognitive impairment (MCI) patients and healthy volunteers. Posiphen (4×60 mg/day ×10 days) administered to MCI patients for 10 days lowers their CSF levels of sAPPα, sAPPβ and t-τ to those determined in healthy (Posiphen naive) volunteers. Biomarker concentrations are expressed as a per cent of MCI predrug values (assigned as 100%) and combined all data across assays (AlphaLisa and <t>MSD</t> for sAPPα and sAPPβ, and AlphaLisa and Innogenetics for t-τ) in Table 3 . Whereas there were significant Posiphen-induced declines in MCI subjects (see Table 3 for statistical analyses), no dramatic differences were evident between Posiphen-treated MCI subjects and healthy volunteers.
    Meso Scale Discovery Msd, supplied by Meso Scale Diagnostics LLC, used in various techniques. Bioz Stars score: 94/100, based on 2126 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/meso scale discovery msd/product/Meso Scale Diagnostics LLC
    Average 94 stars, based on 2126 article reviews
    Price from $9.99 to $1999.99
    meso scale discovery msd - by Bioz Stars, 2020-09
    94/100 stars
      Buy from Supplier

    msd  (Janssen)
    92
    Janssen msd
    Comparison of <t>sAPPα,</t> sAPPβ and t-τ between untreated and treated mild cognitive impairment (MCI) patients and healthy volunteers. Posiphen (4×60 mg/day ×10 days) administered to MCI patients for 10 days lowers their CSF levels of sAPPα, sAPPβ and t-τ to those determined in healthy (Posiphen naive) volunteers. Biomarker concentrations are expressed as a per cent of MCI predrug values (assigned as 100%) and combined all data across assays (AlphaLisa and <t>MSD</t> for sAPPα and sAPPβ, and AlphaLisa and Innogenetics for t-τ) in Table 3 . Whereas there were significant Posiphen-induced declines in MCI subjects (see Table 3 for statistical analyses), no dramatic differences were evident between Posiphen-treated MCI subjects and healthy volunteers.
    Msd, supplied by Janssen, used in various techniques. Bioz Stars score: 92/100, based on 711 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/msd/product/Janssen
    Average 92 stars, based on 711 article reviews
    Price from $9.99 to $1999.99
    msd - by Bioz Stars, 2020-09
    92/100 stars
      Buy from Supplier

    94
    AstraZeneca msd
    Comparison of <t>sAPPα,</t> sAPPβ and t-τ between untreated and treated mild cognitive impairment (MCI) patients and healthy volunteers. Posiphen (4×60 mg/day ×10 days) administered to MCI patients for 10 days lowers their CSF levels of sAPPα, sAPPβ and t-τ to those determined in healthy (Posiphen naive) volunteers. Biomarker concentrations are expressed as a per cent of MCI predrug values (assigned as 100%) and combined all data across assays (AlphaLisa and <t>MSD</t> for sAPPα and sAPPβ, and AlphaLisa and Innogenetics for t-τ) in Table 3 . Whereas there were significant Posiphen-induced declines in MCI subjects (see Table 3 for statistical analyses), no dramatic differences were evident between Posiphen-treated MCI subjects and healthy volunteers.
    Msd, supplied by AstraZeneca, used in various techniques. Bioz Stars score: 94/100, based on 702 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/msd/product/AstraZeneca
    Average 94 stars, based on 702 article reviews
    Price from $9.99 to $1999.99
    msd - by Bioz Stars, 2020-09
    94/100 stars
      Buy from Supplier

    92
    Novo Nordisk msd
    Comparison of <t>sAPPα,</t> sAPPβ and t-τ between untreated and treated mild cognitive impairment (MCI) patients and healthy volunteers. Posiphen (4×60 mg/day ×10 days) administered to MCI patients for 10 days lowers their CSF levels of sAPPα, sAPPβ and t-τ to those determined in healthy (Posiphen naive) volunteers. Biomarker concentrations are expressed as a per cent of MCI predrug values (assigned as 100%) and combined all data across assays (AlphaLisa and <t>MSD</t> for sAPPα and sAPPβ, and AlphaLisa and Innogenetics for t-τ) in Table 3 . Whereas there were significant Posiphen-induced declines in MCI subjects (see Table 3 for statistical analyses), no dramatic differences were evident between Posiphen-treated MCI subjects and healthy volunteers.
    Msd, supplied by Novo Nordisk, used in various techniques. Bioz Stars score: 92/100, based on 797 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/msd/product/Novo Nordisk
    Average 92 stars, based on 797 article reviews
    Price from $9.99 to $1999.99
    msd - by Bioz Stars, 2020-09
    92/100 stars
      Buy from Supplier

    msd  (Sanofi)
    94
    Sanofi msd
    Comparison of <t>sAPPα,</t> sAPPβ and t-τ between untreated and treated mild cognitive impairment (MCI) patients and healthy volunteers. Posiphen (4×60 mg/day ×10 days) administered to MCI patients for 10 days lowers their CSF levels of sAPPα, sAPPβ and t-τ to those determined in healthy (Posiphen naive) volunteers. Biomarker concentrations are expressed as a per cent of MCI predrug values (assigned as 100%) and combined all data across assays (AlphaLisa and <t>MSD</t> for sAPPα and sAPPβ, and AlphaLisa and Innogenetics for t-τ) in Table 3 . Whereas there were significant Posiphen-induced declines in MCI subjects (see Table 3 for statistical analyses), no dramatic differences were evident between Posiphen-treated MCI subjects and healthy volunteers.
    Msd, supplied by Sanofi, used in various techniques. Bioz Stars score: 94/100, based on 721 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/msd/product/Sanofi
    Average 94 stars, based on 721 article reviews
    Price from $9.99 to $1999.99
    msd - by Bioz Stars, 2020-09
    94/100 stars
      Buy from Supplier

    92
    Astellas msd
    Comparison of <t>sAPPα,</t> sAPPβ and t-τ between untreated and treated mild cognitive impairment (MCI) patients and healthy volunteers. Posiphen (4×60 mg/day ×10 days) administered to MCI patients for 10 days lowers their CSF levels of sAPPα, sAPPβ and t-τ to those determined in healthy (Posiphen naive) volunteers. Biomarker concentrations are expressed as a per cent of MCI predrug values (assigned as 100%) and combined all data across assays (AlphaLisa and <t>MSD</t> for sAPPα and sAPPβ, and AlphaLisa and Innogenetics for t-τ) in Table 3 . Whereas there were significant Posiphen-induced declines in MCI subjects (see Table 3 for statistical analyses), no dramatic differences were evident between Posiphen-treated MCI subjects and healthy volunteers.
    Msd, supplied by Astellas, used in various techniques. Bioz Stars score: 92/100, based on 575 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/msd/product/Astellas
    Average 92 stars, based on 575 article reviews
    Price from $9.99 to $1999.99
    msd - by Bioz Stars, 2020-09
    92/100 stars
      Buy from Supplier

    94
    Bristol Myers msd
    Comparison of <t>sAPPα,</t> sAPPβ and t-τ between untreated and treated mild cognitive impairment (MCI) patients and healthy volunteers. Posiphen (4×60 mg/day ×10 days) administered to MCI patients for 10 days lowers their CSF levels of sAPPα, sAPPβ and t-τ to those determined in healthy (Posiphen naive) volunteers. Biomarker concentrations are expressed as a per cent of MCI predrug values (assigned as 100%) and combined all data across assays (AlphaLisa and <t>MSD</t> for sAPPα and sAPPβ, and AlphaLisa and Innogenetics for t-τ) in Table 3 . Whereas there were significant Posiphen-induced declines in MCI subjects (see Table 3 for statistical analyses), no dramatic differences were evident between Posiphen-treated MCI subjects and healthy volunteers.
    Msd, supplied by Bristol Myers, used in various techniques. Bioz Stars score: 94/100, based on 367 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/msd/product/Bristol Myers
    Average 94 stars, based on 367 article reviews
    Price from $9.99 to $1999.99
    msd - by Bioz Stars, 2020-09
    94/100 stars
      Buy from Supplier

    92
    Boehringer Ingelheim msd
    Comparison of <t>sAPPα,</t> sAPPβ and t-τ between untreated and treated mild cognitive impairment (MCI) patients and healthy volunteers. Posiphen (4×60 mg/day ×10 days) administered to MCI patients for 10 days lowers their CSF levels of sAPPα, sAPPβ and t-τ to those determined in healthy (Posiphen naive) volunteers. Biomarker concentrations are expressed as a per cent of MCI predrug values (assigned as 100%) and combined all data across assays (AlphaLisa and <t>MSD</t> for sAPPα and sAPPβ, and AlphaLisa and Innogenetics for t-τ) in Table 3 . Whereas there were significant Posiphen-induced declines in MCI subjects (see Table 3 for statistical analyses), no dramatic differences were evident between Posiphen-treated MCI subjects and healthy volunteers.
    Msd, supplied by Boehringer Ingelheim, used in various techniques. Bioz Stars score: 92/100, based on 485 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/msd/product/Boehringer Ingelheim
    Average 92 stars, based on 485 article reviews
    Price from $9.99 to $1999.99
    msd - by Bioz Stars, 2020-09
    92/100 stars
      Buy from Supplier

    94
    Eli Lilly msd
    Comparison of <t>sAPPα,</t> sAPPβ and t-τ between untreated and treated mild cognitive impairment (MCI) patients and healthy volunteers. Posiphen (4×60 mg/day ×10 days) administered to MCI patients for 10 days lowers their CSF levels of sAPPα, sAPPβ and t-τ to those determined in healthy (Posiphen naive) volunteers. Biomarker concentrations are expressed as a per cent of MCI predrug values (assigned as 100%) and combined all data across assays (AlphaLisa and <t>MSD</t> for sAPPα and sAPPβ, and AlphaLisa and Innogenetics for t-τ) in Table 3 . Whereas there were significant Posiphen-induced declines in MCI subjects (see Table 3 for statistical analyses), no dramatic differences were evident between Posiphen-treated MCI subjects and healthy volunteers.
    Msd, supplied by Eli Lilly, used in various techniques. Bioz Stars score: 94/100, based on 385 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/msd/product/Eli Lilly
    Average 94 stars, based on 385 article reviews
    Price from $9.99 to $1999.99
    msd - by Bioz Stars, 2020-09
    94/100 stars
      Buy from Supplier

    92
    Gilead Sciences msd
    Comparison of <t>sAPPα,</t> sAPPβ and t-τ between untreated and treated mild cognitive impairment (MCI) patients and healthy volunteers. Posiphen (4×60 mg/day ×10 days) administered to MCI patients for 10 days lowers their CSF levels of sAPPα, sAPPβ and t-τ to those determined in healthy (Posiphen naive) volunteers. Biomarker concentrations are expressed as a per cent of MCI predrug values (assigned as 100%) and combined all data across assays (AlphaLisa and <t>MSD</t> for sAPPα and sAPPβ, and AlphaLisa and Innogenetics for t-τ) in Table 3 . Whereas there were significant Posiphen-induced declines in MCI subjects (see Table 3 for statistical analyses), no dramatic differences were evident between Posiphen-treated MCI subjects and healthy volunteers.
    Msd, supplied by Gilead Sciences, used in various techniques. Bioz Stars score: 92/100, based on 184 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/msd/product/Gilead Sciences
    Average 92 stars, based on 184 article reviews
    Price from $9.99 to $1999.99
    msd - by Bioz Stars, 2020-09
    92/100 stars
      Buy from Supplier

    94
    Mundipharma msd
    Comparison of <t>sAPPα,</t> sAPPβ and t-τ between untreated and treated mild cognitive impairment (MCI) patients and healthy volunteers. Posiphen (4×60 mg/day ×10 days) administered to MCI patients for 10 days lowers their CSF levels of sAPPα, sAPPβ and t-τ to those determined in healthy (Posiphen naive) volunteers. Biomarker concentrations are expressed as a per cent of MCI predrug values (assigned as 100%) and combined all data across assays (AlphaLisa and <t>MSD</t> for sAPPα and sAPPβ, and AlphaLisa and Innogenetics for t-τ) in Table 3 . Whereas there were significant Posiphen-induced declines in MCI subjects (see Table 3 for statistical analyses), no dramatic differences were evident between Posiphen-treated MCI subjects and healthy volunteers.
    Msd, supplied by Mundipharma, used in various techniques. Bioz Stars score: 94/100, based on 357 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/msd/product/Mundipharma
    Average 94 stars, based on 357 article reviews
    Price from $9.99 to $1999.99
    msd - by Bioz Stars, 2020-09
    94/100 stars
      Buy from Supplier

    msd  (Amgen)
    92
    Amgen msd
    Comparison of <t>sAPPα,</t> sAPPβ and t-τ between untreated and treated mild cognitive impairment (MCI) patients and healthy volunteers. Posiphen (4×60 mg/day ×10 days) administered to MCI patients for 10 days lowers their CSF levels of sAPPα, sAPPβ and t-τ to those determined in healthy (Posiphen naive) volunteers. Biomarker concentrations are expressed as a per cent of MCI predrug values (assigned as 100%) and combined all data across assays (AlphaLisa and <t>MSD</t> for sAPPα and sAPPβ, and AlphaLisa and Innogenetics for t-τ) in Table 3 . Whereas there were significant Posiphen-induced declines in MCI subjects (see Table 3 for statistical analyses), no dramatic differences were evident between Posiphen-treated MCI subjects and healthy volunteers.
    Msd, supplied by Amgen, used in various techniques. Bioz Stars score: 92/100, based on 317 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/msd/product/Amgen
    Average 92 stars, based on 317 article reviews
    Price from $9.99 to $1999.99
    msd - by Bioz Stars, 2020-09
    92/100 stars
      Buy from Supplier

    93
    ViiV Healthcare msd
    Comparison of <t>sAPPα,</t> sAPPβ and t-τ between untreated and treated mild cognitive impairment (MCI) patients and healthy volunteers. Posiphen (4×60 mg/day ×10 days) administered to MCI patients for 10 days lowers their CSF levels of sAPPα, sAPPβ and t-τ to those determined in healthy (Posiphen naive) volunteers. Biomarker concentrations are expressed as a per cent of MCI predrug values (assigned as 100%) and combined all data across assays (AlphaLisa and <t>MSD</t> for sAPPα and sAPPβ, and AlphaLisa and Innogenetics for t-τ) in Table 3 . Whereas there were significant Posiphen-induced declines in MCI subjects (see Table 3 for statistical analyses), no dramatic differences were evident between Posiphen-treated MCI subjects and healthy volunteers.
    Msd, supplied by ViiV Healthcare, used in various techniques. Bioz Stars score: 93/100, based on 141 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/msd/product/ViiV Healthcare
    Average 93 stars, based on 141 article reviews
    Price from $9.99 to $1999.99
    msd - by Bioz Stars, 2020-09
    93/100 stars
      Buy from Supplier

    94
    Otsuka Holdings msd
    Comparison of <t>sAPPα,</t> sAPPβ and t-τ between untreated and treated mild cognitive impairment (MCI) patients and healthy volunteers. Posiphen (4×60 mg/day ×10 days) administered to MCI patients for 10 days lowers their CSF levels of sAPPα, sAPPβ and t-τ to those determined in healthy (Posiphen naive) volunteers. Biomarker concentrations are expressed as a per cent of MCI predrug values (assigned as 100%) and combined all data across assays (AlphaLisa and <t>MSD</t> for sAPPα and sAPPβ, and AlphaLisa and Innogenetics for t-τ) in Table 3 . Whereas there were significant Posiphen-induced declines in MCI subjects (see Table 3 for statistical analyses), no dramatic differences were evident between Posiphen-treated MCI subjects and healthy volunteers.
    Msd, supplied by Otsuka Holdings, used in various techniques. Bioz Stars score: 94/100, based on 300 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/msd/product/Otsuka Holdings
    Average 94 stars, based on 300 article reviews
    Price from $9.99 to $1999.99
    msd - by Bioz Stars, 2020-09
    94/100 stars
      Buy from Supplier

    94
    Daiichi Sankyo msd
    Comparison of <t>sAPPα,</t> sAPPβ and t-τ between untreated and treated mild cognitive impairment (MCI) patients and healthy volunteers. Posiphen (4×60 mg/day ×10 days) administered to MCI patients for 10 days lowers their CSF levels of sAPPα, sAPPβ and t-τ to those determined in healthy (Posiphen naive) volunteers. Biomarker concentrations are expressed as a per cent of MCI predrug values (assigned as 100%) and combined all data across assays (AlphaLisa and <t>MSD</t> for sAPPα and sAPPβ, and AlphaLisa and Innogenetics for t-τ) in Table 3 . Whereas there were significant Posiphen-induced declines in MCI subjects (see Table 3 for statistical analyses), no dramatic differences were evident between Posiphen-treated MCI subjects and healthy volunteers.
    Msd, supplied by Daiichi Sankyo, used in various techniques. Bioz Stars score: 94/100, based on 197 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/msd/product/Daiichi Sankyo
    Average 94 stars, based on 197 article reviews
    Price from $9.99 to $1999.99
    msd - by Bioz Stars, 2020-09
    94/100 stars
      Buy from Supplier

    94
    Ono Pharma msd
    Comparison of <t>sAPPα,</t> sAPPβ and t-τ between untreated and treated mild cognitive impairment (MCI) patients and healthy volunteers. Posiphen (4×60 mg/day ×10 days) administered to MCI patients for 10 days lowers their CSF levels of sAPPα, sAPPβ and t-τ to those determined in healthy (Posiphen naive) volunteers. Biomarker concentrations are expressed as a per cent of MCI predrug values (assigned as 100%) and combined all data across assays (AlphaLisa and <t>MSD</t> for sAPPα and sAPPβ, and AlphaLisa and Innogenetics for t-τ) in Table 3 . Whereas there were significant Posiphen-induced declines in MCI subjects (see Table 3 for statistical analyses), no dramatic differences were evident between Posiphen-treated MCI subjects and healthy volunteers.
    Msd, supplied by Ono Pharma, used in various techniques. Bioz Stars score: 94/100, based on 192 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/msd/product/Ono Pharma
    Average 94 stars, based on 192 article reviews
    Price from $9.99 to $1999.99
    msd - by Bioz Stars, 2020-09
    94/100 stars
      Buy from Supplier

    msd  (Eisai)
    92
    Eisai msd
    Comparison of <t>sAPPα,</t> sAPPβ and t-τ between untreated and treated mild cognitive impairment (MCI) patients and healthy volunteers. Posiphen (4×60 mg/day ×10 days) administered to MCI patients for 10 days lowers their CSF levels of sAPPα, sAPPβ and t-τ to those determined in healthy (Posiphen naive) volunteers. Biomarker concentrations are expressed as a per cent of MCI predrug values (assigned as 100%) and combined all data across assays (AlphaLisa and <t>MSD</t> for sAPPα and sAPPβ, and AlphaLisa and Innogenetics for t-τ) in Table 3 . Whereas there were significant Posiphen-induced declines in MCI subjects (see Table 3 for statistical analyses), no dramatic differences were evident between Posiphen-treated MCI subjects and healthy volunteers.
    Msd, supplied by Eisai, used in various techniques. Bioz Stars score: 92/100, based on 129 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/msd/product/Eisai
    Average 92 stars, based on 129 article reviews
    Price from $9.99 to $1999.99
    msd - by Bioz Stars, 2020-09
    92/100 stars
      Buy from Supplier

    92
    Agilent technologies msd chemstation software
    Comparison of <t>sAPPα,</t> sAPPβ and t-τ between untreated and treated mild cognitive impairment (MCI) patients and healthy volunteers. Posiphen (4×60 mg/day ×10 days) administered to MCI patients for 10 days lowers their CSF levels of sAPPα, sAPPβ and t-τ to those determined in healthy (Posiphen naive) volunteers. Biomarker concentrations are expressed as a per cent of MCI predrug values (assigned as 100%) and combined all data across assays (AlphaLisa and <t>MSD</t> for sAPPα and sAPPβ, and AlphaLisa and Innogenetics for t-τ) in Table 3 . Whereas there were significant Posiphen-induced declines in MCI subjects (see Table 3 for statistical analyses), no dramatic differences were evident between Posiphen-treated MCI subjects and healthy volunteers.
    Msd Chemstation Software, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 92/100, based on 545 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/msd chemstation software/product/Agilent technologies
    Average 92 stars, based on 545 article reviews
    Price from $9.99 to $1999.99
    msd chemstation software - by Bioz Stars, 2020-09
    92/100 stars
      Buy from Supplier

    92
    Ono Pharma msd k k
    Comparison of <t>sAPPα,</t> sAPPβ and t-τ between untreated and treated mild cognitive impairment (MCI) patients and healthy volunteers. Posiphen (4×60 mg/day ×10 days) administered to MCI patients for 10 days lowers their CSF levels of sAPPα, sAPPβ and t-τ to those determined in healthy (Posiphen naive) volunteers. Biomarker concentrations are expressed as a per cent of MCI predrug values (assigned as 100%) and combined all data across assays (AlphaLisa and <t>MSD</t> for sAPPα and sAPPβ, and AlphaLisa and Innogenetics for t-τ) in Table 3 . Whereas there were significant Posiphen-induced declines in MCI subjects (see Table 3 for statistical analyses), no dramatic differences were evident between Posiphen-treated MCI subjects and healthy volunteers.
    Msd K K, supplied by Ono Pharma, used in various techniques. Bioz Stars score: 92/100, based on 151 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/msd k k/product/Ono Pharma
    Average 92 stars, based on 151 article reviews
    Price from $9.99 to $1999.99
    msd k k - by Bioz Stars, 2020-09
    92/100 stars
      Buy from Supplier

    msd  (Chugai)
    92
    Chugai msd
    Comparison of <t>sAPPα,</t> sAPPβ and t-τ between untreated and treated mild cognitive impairment (MCI) patients and healthy volunteers. Posiphen (4×60 mg/day ×10 days) administered to MCI patients for 10 days lowers their CSF levels of sAPPα, sAPPβ and t-τ to those determined in healthy (Posiphen naive) volunteers. Biomarker concentrations are expressed as a per cent of MCI predrug values (assigned as 100%) and combined all data across assays (AlphaLisa and <t>MSD</t> for sAPPα and sAPPβ, and AlphaLisa and Innogenetics for t-τ) in Table 3 . Whereas there were significant Posiphen-induced declines in MCI subjects (see Table 3 for statistical analyses), no dramatic differences were evident between Posiphen-treated MCI subjects and healthy volunteers.
    Msd, supplied by Chugai, used in various techniques. Bioz Stars score: 92/100, based on 170 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/msd/product/Chugai
    Average 92 stars, based on 170 article reviews
    Price from $9.99 to $1999.99
    msd - by Bioz Stars, 2020-09
    92/100 stars
      Buy from Supplier

    Image Search Results


    Location of WIPO Re:Search anthelmintic drug development partnerships within the product development pipeline. The majority of partnerships facilitated to date involve the sharing of compounds or compound libraries to be screened against the causative agents of schistosomiasis, soil-transmitted helminthiases, onchocerciasis, lymphatic filariasis, and neurocysticercosis. Partners mentioned in this figure include Aberystwyth University, Alnylam Pharmaceuticals, AstraZeneca (AZ), Drugs for Neglected Diseases initiative (DND i ), Eskitis Institute at Griffith University, GlaxoSmithKline (GSK), Liverpool School of Tropical Medicine (Liverpool STM), McGill University, MSD (known as Merck in the US and Canada), US National Institutes of Health (NIH), Swiss Tropical and Public Health Institute (Swiss TPH), University of British Columbia (UBC), University of California, San Francisco (UCSF), and University of Buea. Capacity-building partnerships are not included in the figure. Asterisks (∗, ∗∗, ∗∗∗) represent partnerships focused on multiple diseases.

    Journal: International Journal for Parasitology: Drugs and Drug Resistance

    Article Title: WIPO Re:Search: Accelerating anthelmintic development through cross-sector partnerships

    doi: 10.1016/j.ijpddr.2014.09.002

    Figure Lengend Snippet: Location of WIPO Re:Search anthelmintic drug development partnerships within the product development pipeline. The majority of partnerships facilitated to date involve the sharing of compounds or compound libraries to be screened against the causative agents of schistosomiasis, soil-transmitted helminthiases, onchocerciasis, lymphatic filariasis, and neurocysticercosis. Partners mentioned in this figure include Aberystwyth University, Alnylam Pharmaceuticals, AstraZeneca (AZ), Drugs for Neglected Diseases initiative (DND i ), Eskitis Institute at Griffith University, GlaxoSmithKline (GSK), Liverpool School of Tropical Medicine (Liverpool STM), McGill University, MSD (known as Merck in the US and Canada), US National Institutes of Health (NIH), Swiss Tropical and Public Health Institute (Swiss TPH), University of British Columbia (UBC), University of California, San Francisco (UCSF), and University of Buea. Capacity-building partnerships are not included in the figure. Asterisks (∗, ∗∗, ∗∗∗) represent partnerships focused on multiple diseases.

    Article Snippet: Conflicts of interest J Dent, R Ramamoorthi, and KM Graef are employees of BIO Ventures for Global Health, which receives WIPO Re:Search sponsorship funding from Alnylam, Eisai, GlaxoSmithKline, MSD, Novartis, Pfizer, and Sanofi.

    Techniques:

    Comparison of sAPPα, sAPPβ and t-τ between untreated and treated mild cognitive impairment (MCI) patients and healthy volunteers. Posiphen (4×60 mg/day ×10 days) administered to MCI patients for 10 days lowers their CSF levels of sAPPα, sAPPβ and t-τ to those determined in healthy (Posiphen naive) volunteers. Biomarker concentrations are expressed as a per cent of MCI predrug values (assigned as 100%) and combined all data across assays (AlphaLisa and MSD for sAPPα and sAPPβ, and AlphaLisa and Innogenetics for t-τ) in Table 3 . Whereas there were significant Posiphen-induced declines in MCI subjects (see Table 3 for statistical analyses), no dramatic differences were evident between Posiphen-treated MCI subjects and healthy volunteers.

    Journal: Journal of Neurology, Neurosurgery, and Psychiatry

    Article Title: Posiphen as a candidate drug to lower CSF amyloid precursor protein, amyloid-? peptide and ? levels: target engagement, tolerability and pharmacokinetics in humans

    doi: 10.1136/jnnp-2012-302589

    Figure Lengend Snippet: Comparison of sAPPα, sAPPβ and t-τ between untreated and treated mild cognitive impairment (MCI) patients and healthy volunteers. Posiphen (4×60 mg/day ×10 days) administered to MCI patients for 10 days lowers their CSF levels of sAPPα, sAPPβ and t-τ to those determined in healthy (Posiphen naive) volunteers. Biomarker concentrations are expressed as a per cent of MCI predrug values (assigned as 100%) and combined all data across assays (AlphaLisa and MSD for sAPPα and sAPPβ, and AlphaLisa and Innogenetics for t-τ) in Table 3 . Whereas there were significant Posiphen-induced declines in MCI subjects (see Table 3 for statistical analyses), no dramatic differences were evident between Posiphen-treated MCI subjects and healthy volunteers.

    Article Snippet: Meso Scale Discovery (MSD) assays were used for quantification of sAPPα and sAPPβ (human Alzheimer's panel three sAPPα/sAPPβ assay kit (catalogue#: K15120E-1, MSD, Gaithersburg, Maryland, USA)) from 25 μl of CSF.

    Techniques: Biomarker Assay